Cargando…
Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome
BACKGROUND: Irritable bowel syndrome (IBS) is a brain‐gut disorder, of which the natural course varies between patients and is difficult to predict. This study aimed to evaluate symptom evolution over a 5‐year follow‐up period and to identify baseline predictors for symptom severity and quality of l...
Autores principales: | Weerts, Zsa Zsa R. M., Vork, Lisa, Mujagic, Zlatan, Keszthelyi, Daniel, Hesselink, Martine A. M., Kruimel, Joanna, Leue, Carsten, Muris, Jean W.M., Jonkers, Daisy M. A. E., Masclee, Ad A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852246/ https://www.ncbi.nlm.nih.gov/pubmed/31119844 http://dx.doi.org/10.1111/nmo.13629 |
Ejemplares similares
-
Examining the optimal cutoff values of HADS, PHQ‐9 and GAD‐7 as screening instruments for depression and anxiety in irritable bowel syndrome
por: Snijkers, Johanna T. W., et al.
Publicado: (2021) -
Age-Related Decrease in Abdominal Pain and Associated Structural- and Functional Mechanisms: An Exploratory Study in Healthy Individuals and Irritable Bowel Syndrome Patients
por: Beckers, Abraham B., et al.
Publicado: (2021) -
The Experience Sampling Method—Evaluation of treatment effect of escitalopram in IBS with comorbid panic disorder
por: Vork, Lisa, et al.
Publicado: (2018) -
Integrated fecal microbiome–metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome
por: Mujagic, Zlatan, et al.
Publicado: (2022) -
Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study
por: Weerts, Zsa Zsa R M, et al.
Publicado: (2020)